Transaction in Own Shares

Summary by AI BETAClose X

Jardine Matheson Holdings Limited announced a share repurchase on October 21, 2026, acquiring 67,640 ordinary shares at a weighted average price of US$57.895 per share, with the highest price paid being US$57.9924 and the lowest US$57.13. These repurchased shares will be cancelled, and as of the announcement date, the company's issued share capital stands at 292,674,237 ordinary shares with no treasury shares held. This total number of voting rights serves as the denominator for shareholders to determine notification requirements under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Disclaimer*

Jardine Matheson Hldgs Ltd
21 October 2026
 

JARDINE MATHESON HOLDINGS LIMITED ('JMH')

SHARE REPURCHASE

Please be advised of the following market repurchase by JMH of its ordinary shares:

Date of repurchase:
Total number of shares repurchased:
Highest price paid per share:
Lowest price paid per share:
Weighted average purchase price per share:

21 October 2026
67,640 shares
US$57.9924
US$57.13
US$57.895


The repurchased shares will be cancelled.

In conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1A on a voluntary basis, as at the date of this announcement, JMH's issued share capital consists of 292,674,237 ordinary shares with voting rights of one vote per share. JMH does not hold any treasury shares.

The above figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, JMH under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.


Sean Ward
Company Secretary
Jardine Matheson Holdings Limited

21 October 2026

www.jardines.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings